Medical company with a biotechnology laboratory «Good Cells»

This is the first medical center in central Europe and Asia where regenerated:

• Female endometrium through the cultivation and use of endometrial stem cells,
• White matter of the brain using isolated neural crest stem cells.

This is a new approach in the treatment of infertility, an alternative to artificial insemination. And neural crest cells slow the progression of incurable diseases of the nervous system, such as: stroke, Parkinson’s disease, multiple sclerosis.

Nervous crest cells.

The GoodCells lab’s articles and research papers have been published in global media resources – international BMC and German Spring nature. The main themes of these papers are:

• The treatment of infertility by endometrial repair,
• The effect of deuterium on adipose tissue,
• Characterization of stromal cells,
• Properties of neural crest cells derived from hair follicles.

Patents for:

• A non-cellular biotechnology product for scalp regeneration and enhancing hair growth in combination with and without follicle transplantation;
• A method of making and administering a biotechnology product for the treatment of osteoarthritis prior to surgery, or as a method of improving rehabilitation after surgery;
• A method of treating age-related changes in skin and scars using transplantation of isolated fibroblasts,
• A scheme for the combination of proprietary and donor biologics in the therapy of diabetes mellitus type 2,
• Growing bone implants on nanotubes populated with the patient’s own cells. The material can be used in reconstructive surgery.

.

GoodCells performs a two-phase freezing process. The material is cooled to -80 degrees before being placed in a -198 cryo-fridge. This ensures 100 percent viability of the frozen material.

The size of the biobank is limitless: more than 1,000 people from around the world store their biomaterial here, as Good Cell Labs offers the lowest bioinsurance rates in the world.

Good Cell Labs maintains a permanent biocontainment facility with the lowest rates in the world.

The lab maintains a constant supply of 5.5 billion donor cells for replacement therapy and research. No more than 100 million cells are used per patient at a time. The 5.5 billion is the largest active bank in Europe.

Laboratory maintains a constant stock of 5.5 billion cells for replacement therapy and research.

The only mature mesenchymal stem cells used here are those safe cells that have been proven safe worldwide. At Good Cells, fetal and embryonic cells are carefully filtered and rejected because:

• Their use is unethical,
• It is impossible to control their division rate and direction of development,
• They have a high risk of triggering a oncologic process.

The biotechnologists at GoodCells isolate the right cells, test them, and only then preserve them. The biomaterial travels through vacuum tubes contact-free, from the manipulation room to the sealed laboratory. This eliminates the risk of infection of the material. Here we work with both simple components (PRP and SVF) and more complex components – MSCs, eczosomes.